Gribnau Annerixt, van Zuylen Mark L, Coles Jonathan P, Plummer Mark P, Hermanns Henning, Hermanides Jeroen
Department of Anaesthesiology, Amsterdam UMC Location University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
Department of Paediatric Intensive Care, Amsterdam UMC Location University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
Int J Mol Sci. 2024 Feb 21;25(5):2513. doi: 10.3390/ijms25052513.
Traumatic brain injury (TBI) is a major public health concern with significant consequences across various domains. Following the primary event, secondary injuries compound the outcome after TBI, with disrupted glucose metabolism emerging as a relevant factor. This narrative review summarises the existing literature on post-TBI alterations in glucose metabolism. After TBI, the brain undergoes dynamic changes in brain glucose transport, including alterations in glucose transporters and kinetics, and disruptions in the blood-brain barrier (BBB). In addition, cerebral glucose metabolism transitions from a phase of hyperglycolysis to hypometabolism, with upregulation of alternative pathways of glycolysis. Future research should further explore optimal, and possibly personalised, glycaemic control targets in TBI patients, with GLP-1 analogues as promising therapeutic candidates. Furthermore, a more fundamental understanding of alterations in the activation of various pathways, such as the polyol and lactate pathway, could hold the key to improving outcomes following TBI.
创伤性脑损伤(TBI)是一个重大的公共卫生问题,在各个领域都有重大影响。在原发性损伤之后,继发性损伤会使TBI后的结果更加复杂,其中葡萄糖代谢紊乱成为一个相关因素。这篇叙述性综述总结了关于TBI后葡萄糖代谢改变的现有文献。TBI后,大脑在脑葡萄糖转运方面会发生动态变化,包括葡萄糖转运体和动力学的改变,以及血脑屏障(BBB)的破坏。此外,脑葡萄糖代谢从高糖酵解阶段转变为低代谢,同时糖酵解的替代途径上调。未来的研究应进一步探索TBI患者最佳的、可能是个性化的血糖控制目标,胰高血糖素样肽-1(GLP-1)类似物是很有前景的治疗候选药物。此外,更深入地了解各种途径(如多元醇途径和乳酸途径)激活的改变,可能是改善TBI后结果的关键。